Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review
Onabotulinumtoxin-A (onabotA) is a neurotoxin widely used for several indications, including chronic migraine (CM) preventive treatment, due to its well-demonstrated efficacy, tolerability, and safety. However, onabotA safety during pregnancy and breastfeeding remains unclear, as these populations a...
Saved in:
| Main Authors: | Antonio Russo, Luigi Francesco Iannone, Ilaria Orologio, Veronica Rivi, Alberto Boccalini, Flavia Lo Castro, Marcello Silvestro, Simona Guerzoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/17/4/192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient Satisfaction with Aesthetic Outcomes Following OnabotulinumtoxinA Treatment for Chronic Migraine: A Cross-Sectional Study
by: Magdalena Boczarska-Jedynak, et al.
Published: (2025-06-01) -
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs
by: Damiana Scuteri, et al.
Published: (2025-07-01) -
Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study
by: Fayyaz Ahmed, et al.
Published: (2025-05-01) -
Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01) -
Outcomes following intradetrusor onabotulinumtoxinA in a national cohort of nursing home residents
by: Leo D. Dreyfuss, et al.
Published: (2025-01-01)